Phototherapy of posterior uveal melanomas.
The results of phototherapy on a small series of 19 patients with uveal melanomas are presented. Laser radiation at a wavelength of 620 to 630 nm was used in conjunction with a 5 to 7.5 mg/kg dose of haematoporphyrin derivative administered 24 hours before treatment, with total doses/treatment averaging 960 J/cm2. Eleven patients received two treatments, and one received a third. The longest duration of tumour control to 30 September 1990 was 31 months. Of the 19 patients treated six had complete regression of the tumour, while another five had minor to significant regression. A strong correlation between degree of regression and degree of tumour pigmentation was found, the lighter tumours responding much better than darker tumours. There were also strong indications that if a tumour did not respond to the initial phototherapy it was very unlikely that subsequent phototherapy would provide any further benefit.
Favilla
I
I
Department of Ophthalmology, Monash Medical Centre, Melbourne, Australia.
Barry
W R
WR
Gosbell
A
A
Ellims
P
P
Burgess
F
F
D005451:Fluorescein Angiography; D006414:Hematoporphyrin Photoradiation; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D010858:Pigmentation; D014604:Uveal Neoplasms / Q000188:drug therapy* / Q000473:pathology